Brought to you by 
Lexicon, DuPont Pharmaceuticals swap genomics technologies
13 Jul 1999
Executive Summary
DuPont Pharmaceuticals and Lexicon Genetics are sharing their technologies in mouse genomics. The agreements include Lexicon's right to use DuPont's Cre-lox tissue-specific gene knockout method in support of its OmniBank gene sequence database.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- Product or Technology Swap
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Lexicon, DuPont Pharmaceuticals swap genomics technologies
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice